Effects of a Strength Training Programme in Institutionalized Older Adults With Sarcopenia.

NCT07315789 | Completed

• 1 other identifier: 02
• Study Type: interventional
• Target: 164
• Locations: 1 country
• Sites: 1

Brief Summary

Sarcopenia is one of the main problems in the elderly population. The concept of disease has evolved, as have its treatment strategies. Among these is high-intensity interval training (HIIT). This approach has been little studied in older adults with sarcopenia, especially in institutionalized older adults in nursing homes. So this will be the objective of the study. A randomised clinical trial is being conducted to analyse how these diagnostic criteria for sarcopenia evolve after the application of HIIT compared to a control group.

Conditions

Sarcopenia in Elderly; Institutionalized Older Adults; HIIT

Outcome Measures

Primary Outcomes (1)

• Hand grip strenght

  The researchers used the JAMAR dynamometer

  Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.

Secondary Outcomes (3)

• Muscular mass / appendicular skeletal mass (ASM)

  Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.

• Physical performance

  Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.

• Physical performance 2

  Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.

Study Arms (2)

This group includes institutionalized older adults aged 60 and over for treatment.

EXPERIMENTAL

Other: High-intensity interval strength training: therapeutic exercise programme.

This group includes institutionalized older adults aged 60 and over.

NO INTERVENTION

Interventions

High-intensity interval strength training: therapeutic exercise programme. OTHER

A 12-week high-intensity interval strenght training (HIITs) programme is developed with basic exercises adapted to the living environment of older people. Progress in the exercises over the twelve weeks is measured using the maximum weight that can be lifted in one repetition (1-RM), maximum heart rate (MHR) and the Borg scale.

This group includes institutionalized older adults aged 60 and over for treatment.

Eligibility Criteria

• Age: 60 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• older adults who have been institutionalized for at least one year
• older adults who are institutionalized with clinical suspicion of sarcopenia according to the Sarc-F questionnaire and muscle strength criteria
• older adults residing in the community of Extremadura.

You may not qualify if:

• present cognitive impairment (score \<24 Mini-Mental State Examination)
• primary, serious, or chronic diseases that could explain the decrease in muscle strength and the other diagnostic variables of the participants
• diseases or physical disorders that hinder the assessment of the participants; -use of drugs that may affect muscle strength and mass.

Sponsors & Collaborators

• University of Extremadura: lead

Study Sites (1)

Universidad de Extremadura

Badajoz, Spain

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: QUADRUPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical professor

Study Record Dates

• First Submitted: December 10, 2025
• First Posted: January 2, 2026
• Study Start: February 1, 2022
• Primary Completion: December 15, 2025
• Study Completion: December 15, 2025
• Last Updated: March 17, 2026

Record last verified: 2026-03

Locations

ES (1)